My Pancreatic Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
My Pancreatic Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using biomarkers (KRAS, BRCA1/2) available?
I need to pause here and address an important discrepancy in your medical information that affects how I can help you.
⚠️ CRITICAL CLARIFICATION NEEDED
Your medical profile shows prostate cancer (confirmed diagnosis with detailed staging: T3bN0MX, Gleason 4+3 to 4+5), but your question asks about pancreatic cancer recurrence.
These are two different cancers with completely different treatment approaches. Before I provide guidance, I need to understand:
1. Which cancer are you asking about?
- Your prostate cancer (which appears to be your primary diagnosis based on your records)
- A pancreatic cancer (which would be a separate diagnosis)
- Both cancers (which would be a rare dual diagnosis)
2. Has your medical team confirmed pancreatic cancer?
- If yes, this is important new information that changes everything about treatment planning
- If this was a question you meant to ask about your prostate cancer, I can help clarify that
WHY THIS MATTERS
The biomarkers you've been tested for (BRCA1/2, ATM, TP53, PTEN, etc.) are relevant to prostate cancer treatment decisions, but pancreatic cancer uses different biomarkers (KRAS, BRCA1/2, PALB2, etc.) and has entirely different treatment pathways.
Your recent lab work shows prostate cancer with:
- ATM mutation (abnormal) ✓ Relevant to prostate cancer treatment
- TP53 mutation (abnormal) ✓ Relevant to prostate cancer treatment
- BRCA2 testing (completed) ✓ Relevant to prostate cancer treatment
WHAT I CAN HELP WITH ONCE CLARIFIED
Once you clarify which cancer you're asking about, I can:
✅ For prostate cancer: Explain how your ATM and TP53 mutations affect treatment options, discuss PARP inhibitor eligibility, and help you understand your 18-year treatment history
✅ For pancreatic cancer: Explain biomarker-driven treatment options and clinical trial eligibility
✅ For both: Help you formulate questions about managing multiple cancer diagnoses
Please clarify: Are you asking about recurrent prostate cancer, pancreatic cancer, or both? This will help me give you accurate, personalized educational information.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with treatment for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ